OCSL Stock Cash Flow Statements

Oaktree Specialty Lending Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Financing Cash Flow

Oaktree Specialty Lending Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30

operating activities:
net increase in net assets resulting from operations	38,352,000	-36,249,000	7,239,000	36,913,000	1,120,000	9,337,000	10,535,000	45,952,000	36,685,000	21,522,000	13,172,000	13,208,000	-37,834,000	14,441,000	39,408,000	36,561,000	47,038,000	88,117,000	65,544,000	70,617,000	-64,511,898	15,670,992	17,447,906	5,375,351	-1,888,228
adjustments to reconcile net increase in net assets resulting from operations to net cash from operating activities:
net unrealized (appreciation) depreciation	-18,572,000	82,023,000	19,614,000	-43,179,000	-26,199,000	25,252,000	25,025,000	-13,745,000	1,039,000	18,279,000	22,982,000	17,869,000	86,755,000	27,038,000	4,586,000	2,098,000	-3,917,000	-65,144,000	-47,556,000	-39,468,000
net realized (gains) losses	13,432,000	-6,705,000	17,310,000	51,848,000	69,452,000	6,603,000	8,453,000	13,238,000	10,603,000	6,111,000	3,203,000	2,756,000	-9,212,000	-1,402,000	-9,321,000	-3,739,000	-8,610,000	-5,856,000	-8,215,000	-6,447,000
pik interest income	-5,070,000	-4,531,000	-5,728,000	-6,018,000	-6,149,000	-4,816,000	-3,849,000	-5,544,000	-3,967,000	-4,123,000	-6,130,000	-6,011,000	-5,178,000	-4,674,000	-4,663,000	-4,960,000	-4,597,000	-3,801,000	-3,089,000	-2,573,000	1,325,091	-3,471,403	-3,143,688	-3,326,080
accretion of original issue discount on investments	-4,156,000	-4,460,000	-4,880,000	-5,974,000	-3,736,000	-2,939,000	-5,342,000	-6,760,000	-5,611,000	-4,816,000	-5,127,000	-6,384,000	-6,332,000	-9,299,000	-7,076,000	-11,359,000	-10,255,000	-4,634,000	-3,143,000	-3,927,000	-7,569,073	-420,290	-388,637	-200,901	-243,749
accretion of original issue discount on unsecured notes payable	200,000	278,000	326,000	326,000	326,000	326,000	326,000	274,000	170,000	169,000	170,000	170,000	170,000	169,000	170,000	169,000	149,000	127,000	127,000	127,000
amortization of deferred financing costs	5,155,000	1,271,000	1,274,000	1,274,000	1,267,000	1,247,000	1,248,000	1,192,000	1,571,000	1,008,000	828,000	939,000	938,000	939,000	924,000	1,121,000	1,707,000	687,000	636,000	622,000	609,846	546,059	409,095	368,893
deferred taxes			14,000	0	0	0	-5,000	2,700,000	-925,000	-70,000	-35,000	11,000	-30,000	5,000	-959,000	21,000	-208,000	595,000	-275,000	-81,000
purchases of investments	-138,497,000	-399,068,000	-201,805,000	-255,760,000	-292,185,000	-373,608,000	-359,866,000	-144,482,000	-235,627,000	-100,631,000	-261,404,000	-81,220,000	-123,264,000	-250,956,000	-246,623,000	-405,377,000	-173,300,000	-297,750,000	-243,741,000	-150,295,000
proceeds from the sales and repayments of investments	231,531,000	287,843,000	352,454,000	362,464,000	183,582,000	322,552,000	217,624,000	390,812,000	258,303,000	154,029,000	108,831,000	138,812,000	138,683,000	181,230,000	235,020,000	205,349,000	188,064,000	228,927,000	169,821,000	191,212,000
changes in operating assets and liabilities:
increase in interest, dividends and fees receivable	-125,000	2,523,000	13,196,000	-10,877,000	8,893,000	2,092,000	1,533,000	-12,288,000	-195,000	14,903,000	-1,842,000	-6,659,000	-12,154,000	902,000	1,796,000	-5,061,000	-3,771,000	2,185,000	-1,848,000	965,000
increase in due from portfolio companies	20,000	91,000	12,122,000	-11,576,000	843,000	6,115,000	-1,595,000	-4,237,000	-58,000	4,264,000	16,314,000	-15,614,000	-4,543,000	455,000	-803,000	-596,000	1,889,000	-565,000	632,000	-6,000
increase in receivables from unsettled transactions	7,557,000	37,135,000	-38,113,000	1,212,000	1,612,000	3,559,000	31,510,000	-16,180,000	-24,822,000	-5,774,000	-3,966,000	-1,418,000	6,619,000	15,930,000	-17,673,000	-5,685,000	34,003,000	-23,873,000	-1,931,000	4,983,000
increase in due from broker	9,640,000	-3,310,000	-4,820,000	13,250,000	10,320,000	-14,110,000	27,740,000	-14,270,000	5,700,000	-5,930,000	5,770,000	-9,190,000	-11,220,000	-21,670,000	-1,810,000	0
increase in other assets	-5,555,000	407,000	-662,000	1,824,000	-103,000	90,000	-905,000	562,000	418,000	1,580,000	-2,546,000	-398,000	1,243,000	338,000	-564,000	17,000	-15,000	24,843,000	-26,272,000	109,000
increase in accounts payable, accrued expenses and other liabilities	-2,434,000	-91,000	-121,000	-578,000	-705,000	502,000	323,000	-828,000	174,000	-51,910,000	-554,000	1,377,000	-72,000	-3,773,000	3,145,000	-902,000	516,000	-1,354,000	1,314,000	169,000	-787,045	-21,443	122,488
increase in base management fee and incentive fee payable	271,000	-1,598,000	-6,587,000	102,000	-3,141,000	-449,000	-542,000	-526,000	683,000	-1,577,000	931,000	377,000	-7,270,000	-3,357,000	-6,459,000	1,522,000	6,567,000	2,409,000	9,018,000	-1,777,000
increase in due to affiliate	1,104,000	-231,000	-2,580,000	-715,000	1,030,000	-43,000	-494,000	-3,415,000	3,712,000	31,000	80,000	-360,000	291,000	-254,000	-854,000	-654,000	323,000	1,225,000	225,000	-83,000
increase in interest payable	-1,841,000	-3,513,000	1,369,000	-3,098,000	3,260,000	-2,911,000	2,973,000	3,101,000	-1,944,000	-2,210,000	5,432,000	-420,000	3,977,000	-2,319,000	2,101,000	-681,000	1,918,000	-2,640,000	2,566,000	-2,599,000	1,558,813	-494,815	865,002	142,944	115,159
increase in payables from unsettled transactions	-110,202,000	110,202,000	-15,666,000	-35,929,000	-9,425,000	3,741,000	46,273,000	8,221,000	2,785,000	-20,974,000	-6,007,000	18,425,000	2,134,000	-34,381,000	32,717,000	-2,502,000	1,343,000	-93,492,000	102,259,000	-6,694,000
net cash from operating activities	21,079,000	62,003,000	143,956,000	95,509,000	-59,938,000	-17,620,000	1,125,000	243,777,000	48,703,000	46,180,000	-109,898,000	66,232,000	23,701,000	-90,723,000	23,185,000	-194,658,000	77,204,000	-129,139,000	16,072,000	54,854,000
financing activities:
distributions paid in cash	-33,245,000	-37,111,000	-43,780,000	-43,684,000	-43,307,000	-42,862,000	-46,961,000	-40,929,000	-41,271,000	-41,100,000	-56,746,000	-30,191,000	-29,382,000	-28,505,000	-27,170,000	-25,541,000	-22,927,000	-16,404,000	-14,978,000	-14,300,000
borrowings under credit facilities	80,000,000	200,000,000	125,000,000	50,000,000	135,000,000	50,000,000	20,000,000	0	280,000,000	90,000,000	202,000,000	10,000,000	65,000,000	155,000,000	70,000,000	180,000,000	150,000,000			0	-92,000,000	252,000,000	126,000,000	0
repayments of borrowings under credit facilities	-90,000,000	-340,000,000	-175,000,000	-130,000,000	-75,000,000	-30,000,000	-20,000,000	-425,000,000	-260,000,000	-60,000,000	-42,000,000	-55,000,000	-65,000,000	-60,000,000	-50,000,000	-14,057,000	-500,725,000	0	-14,800,000	-52,000,000	110,000,000	-207,000,000	-37,000,000	0
repayments of unsecured notes	0																			0
issuance of unsecured notes	0															0				0
shares issued under the "at the market" offering	0			0	14,293,000	46,057,000	32,398,000					0	1,243,000
repurchases of common stock under dividend reinvestment plan	-3,751,000	-4,289,000	-1,455,000					0	-1,123,000			-983,000				-611,000	-520,000	-511,000	-528,000	-501,000
shares issued in private placement	0
deferred financing costs paid	-4,846,000			0				-3,282,000				0	0	0	-334,000	-1,046,000	-7,484,000	-72,000	-288,000	0	-496,475	-2,368,750	-1,969,775	-1,046,500
deferred offering costs paid	0	-5,000	-38,000	0	53,000	-85,000	-85,000													0
net cash from financing activities	-51,842,000	-82,000,000	-95,273,000	-125,235,000	30,000,000	23,110,000	-14,648,000	-171,379,000	-29,844,000	-12,445,000	103,254,000	-76,174,000	-29,070,000	85,933,000	-7,504,000	138,745,000	-32,636,000	148,672,000	-30,594,000	-66,801,000	-61,285,569	178,788,542	125,630,027
effect of exchange rate changes on foreign currency	2,354,000	2,133,000	-1,154,000	955,000	-240,000	305,000	-319,000	481,000	788,000	33,000	-475,000	-9,000	-77,000	494,000	-1,259,000	19,000	-768,000	-38,000	-340,000	315,000
net increase in cash and cash equivalents and restricted cash	-28,409,000	-17,864,000	47,529,000	-28,771,000	-30,178,000	5,795,000	-13,842,000	72,879,000	19,647,000	33,768,000	-7,119,000	-9,951,000	-5,446,000	-4,296,000	14,422,000	-55,894,000	43,800,000
cash and cash equivalents and restricted cash, beginning of period	0	0	78,543,000	0	0	0	145,539,000	0	0	0	26,364,000	0	0	0	31,635,000	0	0
cash and cash equivalents and restricted cash, end of period	-28,409,000	-17,864,000	126,072,000	-28,771,000	-30,178,000	5,795,000	131,697,000	72,879,000	19,647,000	33,768,000	19,245,000	-9,951,000	-5,446,000	-4,296,000	46,057,000	-55,894,000	43,800,000
supplemental information:
cash paid for interest	27,547,000	30,155,000	27,593,000	33,556,000	27,660,000	33,219,000	27,623,000	27,760,000	30,996,000	25,144,000	14,289,000	15,062,000	6,785,000	11,119,000	6,205,000	8,423,000	4,423,000	8,394,000	2,766,000	7,983,000	13,149,443	2,672,944	664,613	496,931	137,471
non-cash financing activities:
issuance of shares of common stock under dividend reinvestment plan				0	1,873,000	1,853,000	1,936,000	1,503,000	-1,295,000	1,295,000	1,933,000	983,000	874,000	766,000	786,000	610,000	521,000	511,000	528,000	501,000	-959,457	1,386,483	949,974	283,991	466,225
deferred financing costs	-126,000			0				317,000								430,000	-535,000	0	-57,000
reconciliation to the consolidated statements of assets and liabilities
cash and cash equivalents	-18,039,000	-15,075,000	112,913,000	-32,355,000	-28,710,000	12,662,000	112,369,000	76,746,000	15,954,000	26,368,000	17,382,000	-10,778,000	-5,060,000	-4,399,000	43,765,000	-55,355,000	44,817,000	15,638,000	24,234,000
restricted cash		-2,789,000	13,159,000	3,584,000	-1,468,000	-6,867,000	19,328,000	-3,867,000	3,693,000	7,400,000	1,863,000	827,000	-386,000	103,000	2,292,000	-539,000	-1,017,000
total cash and cash equivalents and restricted cash	-28,409,000	-17,864,000	126,072,000	-28,771,000	-30,178,000	5,795,000	131,697,000	72,879,000	19,647,000	33,768,000	19,245,000	-9,951,000	-5,446,000	-4,296,000	46,057,000	-55,894,000	43,800,000	19,495,000	24,234,000
portfolio company
control investments
c5 technology holdings, llc
continental intermodal group lp
dominion diagnostics, llc
ocsi glick jv llc
senior loan fund jv i, llc
sio2 medical products, inc.
total control investments
affiliate investments
all web leads, inc.
assembled brands capital llc
the avery
telestream 2 llc
total affiliate investments
non-control/non-affiliate investments
107-109 beech oak22 llc
1261229 bc ltd
107 fair street llc
112-126 van houten real22 llc
a.t. holdings ii ltd.
increase in director fees payable							160,000	0	9,000				0	-85,000	123,000	0	0
cash received in the osi2 merger									0
deferred offering costs
issuance of shares in connection with the osi2 merger									0
caregiver services, inc.
a.t. holdings ii sÀrl
access cig, llc
offering costs
accupac, inc.
acquia inc.
adb companies, llc
cash received from mergers
repayments of secured borrowings																0	0
offering costs paid								-49,000	-136,000			0	-57,000									-313,247	-178,492	-332,788	-223,833
issuance of shares in connection with mergers
adc therapeutics sa
aden & anais merger sub, inc.
portfolio company/type of investment
829 common units
34,984,460.37 preferred units
first lien term loan, libor+5.00% cash due 2/28/2024
first lien revolver, libor+5.00% cash due 2/28/2024
30,030.8 common units in dd healthcare services holdings, llc
subordinated debt, libor+4.50% cash due 10/20/2028
87.5% equity interest
subordinated debt, libor+7.00% cash due 12/29/2028
87.5% llc equity interest
first lien revolver, libor+6.75% cash due 10/17/2023
1,609,201 class a units
1,019,168.80 preferred units, 6%
70,424.5641 class a warrants (exercise price 3.3778) expiration date 9/9/2029
1,080,399 shares of series a preferred stock, 10%
first lien delayed draw term loan, 12.50% cash due 5/17/2024
first lien delayed draw term loan, 12.00% cash due 5/4/2024
first lien revenue interest financing term loan 14.25% cash due 9/13/2029
first lien term loan, 12.50% pik due 1/20/2023
second lien term loan, libor+7.75% cash due 2/27/2026
cash acquired in the ocsi merger
issuance of shares in connection with the ocsi merger
109 montgomery owner llc
first lien term loan, libor+7.00% cash due 2/2/2023
first lien delayed draw term loan, libor+7.00% cash due 2/2/2023
first lien term loan, 10.50% pik due 12/22/2022
first lien term loan, sofr+5.50% cash due 1/16/2026
first lien delayed draw term loan, sofr+5.50% cash due 1/16/2026
first lien revolver, sofr+5.50% cash due 1/16/2026
cash acquired in the mergers																0	0
issuance of shares in connection with the mergers																0	0
first lien term loan, 9.50% pik due 12/22/2022
first lien term loan, libor+7.00% cash due 10/31/2025
first lien revolver, libor+7.00% cash due 10/31/2025
first lien term loan, 9.50% cash due 12/22/2022
first lien term loan, libor+3.75% cash due 2/27/2025
first lien term loan, libor+5.50% cash due 1/17/2026
first lien delayed draw term loan, libor+5.50% cash due 1/17/2026
first lien revolver, libor+5.50% cash due 1/17/2026
first lien term loan, libor+6.00% cash due 1/17/2026
first lien delayed draw term loan, libor+6.00% cash due 1/17/2026
first lien revolver, libor+6.00% cash due 1/17/2026
increase in amounts payable to syndication partners
extinguishment of secured borrowings
first star speir aviation limited
first lien term loan, 9.00% cash due 12/15/2025
100% equity interest
first lien revolver, libor+6.00% cash due 10/17/2023
4 over international, llc
first lien term loan, libor+6.00% cash due 6/7/2022
first lien revolver, libor+6.00% cash due 6/7/2022
first lien revolver, prime+5.00% cash due 6/7/2022
first lien revolver, libor+6.00% cash due 6/7/2021
net increase in cash and cash equivalents																			-14,862,000
cash and cash equivalents, beginning of period																			39,096,000			0	76,765,254	0	0
cash and cash equivalents, end of period																			24,234,000			-4,464,345	43,020,557	-29,911,387	83,208,047
new ipt, inc.
first lien term loan, libor+5.00% cash due 3/17/2021
first lien revolver, libor+5.00% cash due 3/17/2021
50.087 class a common units in new ipt holdings, llc
redemption premium on unsecured notes payable
repurchase of unsecured notes
first lien term loan, 9.00% cash due 12/15/2020
99 cents only stores llc
first lien term loan, libor+5.00% cash 1.50% pik due 1/13/2022
first lien term loan, 12.00% cash due 4/27/2023
first lien delayed draw term loan, 12.00% cash due 4/27/2023
thruline marketing, inc.
9,073 class a units in fs avi holdco, llc
first lien delayed draw term loan, libor+6.00% cash due 10/17/2023
cash flows from operating activities:
adjustments to reconcile net increase in net assets resulting from operations to net cash used by operating activities:
net unrealized appreciation on investments and interest rate swap																						372,253	-16,842,523
net realized losses on investments
recognition of fee income																						-3,874,069	-4,527,256	-1,957,795	-1,654,207
change in operating assets and liabilities:
fee income received																						6,005,069	8,005,581	3,747,716	1,667,809
increase in interest and fees receivable																						-975,883	-850,144		-85,993
decrease in due from portfolio company
increase in collateral posted to bank and other assets																						-356,798	438,145
increase in base management fee payable																						1,007,182	902,977	353,160	185,764
increase in incentive fee payable																						625,131	654,762	-148,936	206,513
decrease in due to fsc, inc.
decrease in payments received in advance from portfolio companies																									-55,864
purchases of investments and net revolver activity, net of syndications
principal payments received on investments																						2,302,949	7,883,358	6,284,539	10,559,590
pik interest income received in cash																						1,602,089	5,109,022	836,874
proceeds from the sale of investments																								-3,885,543	0
net cash used by operating activities																						-183,252,887	-159,374,724		-33,364,957
cash flows from financing activities:
dividends paid in cash																						-17,458,086	-16,514,508	-5,168,496	-14,024,206
borrowings under sba debentures payable																						15,000,000	50,300,000	38,000,000
proceeds from the issuance of common stock																						138,928,625	4,992,802	0	101,039,000
net decrease in cash and cash equivalents																						-4,464,345	-33,744,697		83,208,047
lighting by gregory, llc
first lien term loan a, 9.75% due 2/28/2013
first lien bridge loan, 6% due 3/31/2012
97.38% membership interest
nicos polymers & grinding inc.
first lien term loan, 8% due 12/4/2017
first lien revolver, 8% due 12/4/2017
50% membership interest in cd holdco, llc
o’currance, inc.
first lien term loan a, 16.875% due 3/21/2012
first lien term loan b, 16.875%, due 3/21/2012
1.75% preferred membership interest in o’currance holding co., llc
3.3% membership interest in o’currance holding co., llc
mk network, llc
first lien term loan a, 13.5% due 6/1/2012
first lien term loan b, 17.5% due 6/1/2012
first lien revolver, prime + 1.5%
11,030 membership units
second lien term loan a, libor+6.85% (12% floor) due 2/25/2013
second lien term loan b, 16.5% due 2/25/2013
1,080,399 shares of series a preferred stock
cpac, inc.
subordinated term loan, 12.5% due 6/1/2012
net realized (gains) losses on investments																							13,450,219
increase in due from portfolio company																							-48,536	-7,161
increase in due to fsc, inc.																							178,503	219,400
increase in payments received in advance from portfolio companies																							-184,514
purchase of investments																							-238,577,119	-91,777,954	-56,332,856
first lien bridge loan, 8% due 10/15/2010
net unrealized depreciation on investments and interest rate swap
other income
increase in interest receivable
decrease in prepaid management fees
repurchases of common stock
capital contributions
capital withdrawals
proceeds from the issuance of manditorily redeemable preferred stock
redemption of preferred stock
redemption of partnership interests for cash
reinvested shares of common stock under dividend reinvestment plan
redemption of partnership interests
issuance of shares of common stock in exchange for partnership interests
first lien term loan b, 14.5% due 2/28/2013
first lien term loan b, 16.875%, 3/21/2012
vanguard vinyl, inc.
first lien term loan, 12% due 3/30/2013
first lien revolver, libor+7% (10% floor) due 3/30/2013
25,641 shares of series a preferred stock
25,641 shares of common stock
repechage investments limited
first lien term loan, 15.5% due 10/16/2011
7,500 shares of series a preferred stock of elephant & castle, inc.
net unrealized depreciation on investments
net realized loss on investments																									0
increase in prepaid expenses and other assets																									1,691,422
decrease in accounts payable, accrued expenses and other liabilities																									-305,997
net cash provided (used) by financing activities
martini park, llc
first lien term loan, 14% due 2/20/2013
5% membership interest
subordinated term loan, 17.5% due 4/13/2012
net unrealized (appreciation) depreciation on investments
pik interest income, net of cash received
borrowings
repayments of borrowings
portfolio company /type of investment
second lien term loan, 17.5% due 4/13/2012
change in unrealized depreciation on investments
realized (gains) losses on investments
proceeds from the issuance of mandatorily redeemable preferred stock
first lien term loan b, 16.875% due 3/21/2012
charge-off of cost basis of impaired loan
2,297 shares of common stock
elephant & castle, inc.
second lien term loan, 15.5% due 4/20/2012
7,500 shares of series a preferred stock
rose tarlow, inc.
first lien term loan, 12% due 1/25/2014
first lien revolver, libor+4%
6.9% membership interest in rtmh acquisition company
0.1% membership interest in rtmh acquisition company
best vinyl acquisition corporation
second lien term loan, 12% due 3/30/2013
traffic control & safety corporation
second lien term loan, 15% due 6/29/2014
24,750 shares of series b preferred stock
25,000 shares of common stock
first lien term loan a, libor+5% (10% floor), due 7/17/2012
first lien term loan b, 13.5% due 7/17/2012
3.32% interest in crownbrook acquisition i llc
tba global, llc
second lien term loan a, libor+5% (10% floor), due 8/3/2010
second lien term loan b, 14.5% due 8/3/2012
53,994 senior preferred shares
191,977 shares a shares
fitness edge, llc
first lien term loan a, libor+5.25% (10% floor), due 8/8/2012
first lien term loan b, 15% due 8/8/2012
1,000 common units
filet of chicken
second lien term loan, 14.5% due 7/31/2012
boot barn
second lien term loan, 14.5% due 10/3/2013
24,706 shares of series a preferred stock
1,308 shares of common stock
american hardwoods industries holdings, llc
second lien term loan, 15% due 10/15/2012
24,375 membership units
premier trailer leasing, inc.
second lien term loan, 16.5% due 10/23/2012
285 shares of common stock
pacific press technologies, inc.
second lien term loan, 14.75% due 1/10/2013
33,463 shares of common stock
goldco, llc
second lien term loan, 17.5% due 1/31/2013
1.1% membership interest
rail acquisition corp.
first lien term loan, 17% due 4/1/2013
western emulsions, inc.
second lien term loan, 15% due 6/30/2014
storytellers theaters corporation
first lien term loan, 15% due 7/16/2014
first lien revolver, libor+3.5%
1,692 shares of common stock
20,000 shares of preferred stock
healthdrive corporation
first lien term loan a, 10% due 7/17/2013
first lien term loan b, 13% due 7/17/2013
first lien revolver, 12% due 7/17/2013 — undrawn revolver of 1,500,000
idx corporation
second lien term loan, 14.5% due 7/1/2014
cenegenics, llc
first lien term loan, 17% due 10/27/2013
116,237 common units
izi medical products, inc.
first lien term loan a, 12% due 3/31/2014
first lien term loan b, 16% due 3/31/2014
first lien revolver, 10% due 3/31/2014 — undrawn revolver of 2,500,000
453,755 preferred units of izi holdings, llc
total non-control/non-affiliate investments
total portfolio investments
change in unrealized (appreciation) depreciation on investments
increase in prepaid management fees
non-cash financing activites:

We provide you with 20 years of cash flow statements for Oaktree Specialty Lending stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Oaktree Specialty Lending stock. Explore the full financial landscape of Oaktree Specialty Lending stock with our expertly curated income statements.

The information provided in this report about Oaktree Specialty Lending stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.